From Fungi to Feel-Good: Surprising Benefits of Lion's Mane Mushroom for Battling the Blues

Depression, a prevalent neuropsychiatric disorder affecting millions worldwide, has become a significant concern in our fast-paced modern society [1]. Its debilitating effects on daily life, coupled with the risk of suicidal thoughts, make it crucial to explore effective treatment options [2,3]. That's where Lion's Mane Mushroom enters the spotlight as a promising herbal remedy.

 

Natural alternatives are capturing the attention of both researchers and individuals seeking relief, as herbal remedies have gained popularity due to their potential as cost-effective treatments for depressive disorders, with fewer side effects and well tolerated by patients [4,5].

 

Among the diverse range of medicinal mushrooms, Lion's Mane Mushroom, scientifically known as Hericium erinaceus, has emerged as an exciting contender. Lion's Mane Mushroom, with its distinctive appearance resembling a lion's flowing mane, has been cherished in East Asian countries for centuries. Recent studies have revealed that this unique mushroom holds tremendous potential in promoting nerve and brain health, making it a compelling candidate for the treatment of neurological disorders [6].

 

Depression, being a complex disorder with a multitude of causative factors, challenges our understanding of its origins. However, emerging evidence suggests that Lion's Mane Mushroom might offer therapeutic benefits by addressing the neurodegenerative and neurobiological changes associated with depression [7].

 

Intriguing Pathophysiological Theories of Depression and the Promising Role of Lion's Mane Mushroom

 

In the following section, we will explore the intriguing hypotheses surrounding the pathophysiology of depression and its connection to the therapeutic potential of Lion's Mane Mushroom.

 

So, get ready to embark on a journey into the world of Lion's Mane Mushroom and discover how this natural wonder could potentially bring relief to those battling depressive disorder. Let's unravel the mysteries together and delve into the exciting possibilities that lie ahead.

 

1. Lion's Mane Mushroom Boosts the Monoamine System to Fight Depression:

There’s a theory called the monoamine hypothesis of depression, which suggests that when we're depressed, there's a deficiency in the transmission of certain chemicals in our brain called monoamines, like norepinephrine, serotonin, and dopamine. These chemicals are responsible for regulating our mood, and when they're not working properly, it can contribute to depressive symptoms [8,9].

 

Now, one way to treat depression is by targeting and modulating these monoamine neurotransmitters. In a study by Chiu et al. (2018), they found that when mice were subjected to prolonged stress, it led to a decrease in the levels of these neurotransmitters in a part of the brain called the hippocampus. But here's where things get interesting: when they gave these stressed-out mice a high dose of Lion's Mane Mushroom extract, it actually helped restore the levels of serotonin, norepinephrine, and dopamine in their hippocampus [10].

 

The bioactive compounds in Lion's Mane Mushroom act as MAO inhibitors, which mean they prevent the breakdown of these monoamine neurotransmitters, keeping their levels higher and potentially helping to improve mood [10].

 

In simpler terms, Lion's Mane Mushroom might help boost those important brain chemicals that can be a bit wonky when we're feeling down. By keeping them around longer, it could potentially have a positive impact on our mood and overall well-being.

 

2. Lion's Mane Mushroom Boosts Brain-Derived Neurotrophic Factor (BDNF) to Fight Depression:

There are certain substances called neurotrophic factors that play a role in the health and growth of our brain cells [11,12]. One of these factors is called Brain-Derived Neurotrophic Factor, or BDNF. BDNF has been linked to behaviors associated with depression, like suicidal thoughts and feeling down [13].

 

Interestingly, studies have shown that patients with major depressive disorder often have lower levels of BDNF in their brains, which can lead to problems with brain function and contribute to depressive symptoms [14]. However, the good news is that treatments that increase or restore BDNF levels have been found to alleviate symptoms of depression [15,16]. BDNF is like a key player in the brain's ability to change and adapt, which is known as neuroplasticity. It helps with the formation of new connections between brain cells, the growth of new cells, and their maturation [17].

 

Now, here's where Lion's Mane Mushroom enters the picture! Studies have shown that Lion's Mane Mushroom can activate pathways in our brain, which helps to normalize the levels of BDNF and its associated receptors in the hippocampus, especially in situations of chronic stress [10]. This means that Lion's Mane Mushroom could potentially enhance the brain's ability to adapt and grow, leading to improvements in depressive symptoms.

 

3. Lion's Mane Mushroom Sparks Neurogenesis to Combat Depression:

There’s another theory called the neurotrophic/neurogenic hypothesis of depression. It's all about how our brain's ability to adapt and change, called neuroplasticity, can be affected when we're depressed. When we're under stress or facing aversive situations, our brain's response can go out of whack, leading to depressive symptoms. But here's the interesting part: certain antidepressant medications can actually stimulate adaptive responses in our brain, helping to alleviate those symptoms [18].

 

Another important concept linked to this is neurogenesis, which is the production of new neurons in the brain. The neurogenic hypothesis suggests that stress can negatively impact neurogenesis, while antidepressant treatments can have a positive effect on it [19,20]. Studies have shown that patients with depression often have reduced volumes of a brain region called the hippocampus, which is involved in learning, memory, and emotion [21,22]. But don't worry, here's where Lion's Mane Mushroom comes into play!

 

Lion's Mane Mushroom contains special compounds that can stimulate the production of growth factors in our nervous system, like NGF (nerve growth factor) [23,24]. These growth factors are associated with neurogenesis and the ability of our brain cells to change and adapt [25]. In a study by Ryu et al. (2018), they found that giving mice a chronic high dose of Lion's Mane Mushroom extract led to an increase in the number of new neural cells in a brain region called the dentate gyrus. Basically, it promoted the growth of new neurons and increased their survival in that area [26].

 

So, by taking Lion's Mane Mushroom, we might be able to support the growth of new brain cells, which can have a positive impact on our brain's ability to adapt and fight depression. It's like giving our brain a boost to help it heal and recover.

 

4. Lion's Mane Mushroom Tames Inflammation to Combat Depression:

There is something called the inflammatory hypothesis of depression. It suggests that when we're depressed, there can be an increase in certain substances in our body called pro-inflammatory cytokines. These substances are linked to inflammation and can play a role in depressive symptoms [27,28].

 

Scientists have studied this by using animal models and found that when they exposed the animals to things that cause inflammation, like certain chemicals or stressors, it led to behaviors similar to depression, such as loss of appetite and reduced activity [29,30]. They also observed changes in the levels of these proinflammatory substances in the brain [31,32]. Similarly, in clinical trials, they found that people experiencing depression often have altered levels of these substances [33,34].

 

But here's where Lion's Mane Mushroom comes into play! Studies have shown that certain compounds in Lion's Mane Mushroom, like amycenone and erinacine A, have anti-inflammatory effects. These compounds can help reduce the levels of proinflammatory substances in our body. By doing so, they may contribute to the potential antidepressant effects of Lion's Mane Mushroom [35,36].

 

 

How Clinical Studies Illuminate Lion's Mane Mushroom's Role in Easing Depression

 

The following studies provide some insights into the potential benefits of Lion's Mane Mushroom in alleviating symptoms of depression, anxiety, and sleep disorders in clinical trials. Here are the key findings of each study:

 

• In 2010, Nagano et al. conducted a study on menopause, depression, sleep quality, and general complaints in 30 females. They found that consuming cookies with Lion's Mane Mushroom powder helped alleviate symptoms of depression, anxiety, frustration, and palpitation [37].

 

• In 2014, Inanaga et al. reported an improvement in neurocognitive function in an 86-year-old male patient with recurrent depressive disorder who was treated with Lion's Mane Mushroom extract tablets [38].

 

• In 2015, Okamura et al. conducted a pilot study on female undergraduate students with sleep disorders. After 4 weeks of taking Lion's Mane Mushroom extract tablets, the students showed an increase in a biological index related to anxiety disorders, indicating an improvement in anxiety and sleep quality [39].

 

• A recent Clinical Study included 77 overweight or obese participants with anxiety, depression, binge eating, and sleep disorders. They received daily capsules containing Lion's Mane Mushroom extract for 8 weeks. The results showed significant reductions in depression and anxiety, as well as improvements in sleep disorders. These positive changes were associated with increased levels of pro-BDNF, a growth factor related to brain health [40].

 

It is interesting to note how these studies show promising hints of Lion's Mane Mushroom's effects on mental well-being. Let's keep exploring and learning more about the potential of this incredible mushroom in supporting our mental health!

 

 

REFERENCES

 

1. World Health Organization Depression 2023. [(accessed on 10 July 2023)]; Available online: https://www.who.int/news-room/fact-sheets/detail/depression

 

2. Bartolomucci A., Leopardi R. Stress and depression: Preclinical research and clinical implications. PLoS ONE. 2009;4:e4265.

 

3. McMahon F.J., Buervenich S., Charney D., Lipsky R., Rush A.J., Wilson A.F., Sorant A.J.M., Papanicolaou G.J., Laje G., Fava M., et al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.  J. Hum. Genet. 2006;78:804–814.

 

4. Chan Y.C., Chen C.C., Lee L.Y., Chen W.P. Active Substances for Preventing Hearing Deterioration, the Composition Containing the Active Substances, and the Preparation Method Thereof. 10,405,504. S. Patent. 2019 Sep 10;

 

5. Qureshi N.A., Al-Bedah A.M. Mood disorders and complementary and alternative medicine: A literature review.  Dis. Treat. 2013;9:639–658.

 

6. Thongbai B., Rapior S., Hyde K.D., Wittstein K., Stadler M. Hericium erinaceus, an amazing medicinal mushroom.  Prog. 2015;14:91. doi: 10.1007/s11557-015-1105-4. 

 

7. Brigitta B. Pathophysiology of depression and mechanisms of treatment.  Clin. Neurosci. 2002;4:7–20. 

 

8. Schildkraut J.J. The catecholamine hypothesis of affective disorders: A review of supporting evidence.  J. Psychiatry. 1965;122:509–522.

 

9. Bunney E.W., Davis J.M. Norepinephrine in depressive reactions. A review.  Gen. Psychiatry. 1965;13:483–494.

 

10. Chiu C.H., Chyau C.C., Chen C.C., Lee L.Y., Chen W.P., Liu J.L., Lin W.H., Mong M.C. Erinacine A-enriched Hericium erinaceusmycelium produces antidepressant-like effects through modulating BDNF/PI3K/Akt/GSK-3β signaling in mice.  J. Mol. Sci. 2018;19:341.

 

11. Lee R., Kermani P., Teng K.K., Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. 2001;294:1945–1948.

 

12. Skaper S.D. The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS Neurol. Disord. Drug Targets. 2008;7:46–62.

 

13. Kang H.J., Kim J.M., Lee J.Y., Kim S.Y., Bae K.Y., Kim S.W., Shin I.S., Kim H.R., Shin M.G., Yoon J.S. BDNF promoter methylation and suicidal behavior in depressive patients.  Affect. Disord. 2013;151:679–685.

 

14. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.F., Young L. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.  Psychiatry. 2001;50:260–265.

 

 

15. Lee B.H., Kim H., Park S.H., Kim Y.K. Decreased plasma BDNF level in depressive patients.  Affect. Disord. 2007;101:239–244.

 

16. Castrén E. Neurotrophic effects of antidepressant drugs.  Opin. Pharmacol. 2004;4:58–64.

 

17. Ohira K., Hayashi M. A new aspect of the TrkB signaling pathway in neural plasticity.  Neuropharmacol. 2009;7:276–285.

 

18. Loomer H.P., Saunders J.C., Kline N.S. A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer.  Res. Rep. 1957;8:129–141. 

 

19. Drevets W.C. Neuroimaging and neuropathological studies of depression: Implications for the cognitive-emotional features of mood disorders.  Opin. Neurobiol. 2001;11:240–249.

 

20. Hastings R.S., Parsey R.V., Oquendo M.A., Arango V., Mann J.J. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. 2004;29:952–959.

 

21. MacQueen G.M., Campbell S., McEwen B.S., Macdonald K., Amano S., Joffe R.T., Nahmias C., Young L.T. Course of illness, hippocampal function, and hippocampal volume in major depression.  Natl. Acad. Sci. USA. 2003;100:1387–1392.

 

22. Vermetten E., Vythilingam M., Southwick S.M., Charney D.S., Bremner J.D. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder.  Psychiatry. 2003;54:693–702.

 

23. Kawagishi H., Shimada A., Shirai R., Okamoto K., Ojima F., Sakamoto H., Ishiguro Y., Furukawa S. Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett. 1994;35:1569–1572.

 

24. Kawagishi H., Shimada A., Hosokawa S., Mori H., Sakamoto H., Ishiguro Y., Sakemi S., Bordner J., Kojima N., Furukawa S. Erinacines E, F, and G, stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett. 1996;37:7399–7402.

 

25. Skaper S.D. The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS Neurol. Disord. Drug Targets. 2008;7:46–62.

 

26. Ryu S., Kim H.G., Kim J.Y., Kim S.Y., Cho K.O. Hericium erinaceusextract reduces anxiety and depressive behaviors by promoting hippocampal neurogenesis in the adult mouse brain.  Med. Food. 2018;21:174–180.

 

27. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., Schmidt K. The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain Behav. Immun. 2001;15:199–226.

 

28. Maes M. Cytokines in major depression.  Psychiatry. 1994;36:498–499.

 

29. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996;711:163–174.

 

30. Anisman H., Kokkinidis L., Merali Z. Further evidence for the depressive effects of cytokines: Anhedonia and neurochemical changes. Brain Behav. Immun. 2002;16:544–556.

 

31. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmächer T. Cytokine-associated emotional and cognitive disturbances in humans.  Gen. Psychiatry. 2001;58:445–452.

 

32. Eisenberger N.I., Berkman E.T., Inagaki T.K., Rameson L.T., Mashal N.M., Irwin M.R. Inflammation-induced anhedonia: Endotoxin reduces ventral striatum responses to reward.  Psychiatry. 2010;68:748–754.

 

33. Bossù P., Cutuli D., Palladino I., Caporali P., Angelucci F., Laricchiuta D., Gelfo F., De Bartolo P., Caltagirone C., Petrosini L. A single intraperitoneal injection of endotoxin in rats induces long-lasting modifications in behavior and brain protein levels of TNF-α and IL-18.  Neuroinflamm. 2012;9:101.

 

34. Talarowska M., Szemraj J., Gałecki P. The role of interleukin genes in the course of depression. Open Med. 2016;11:41–48.

 

35. Kuo H.C., Lu C.C., Shen C.H., Tung S.Y., Hsieh M.C., Lee K.C., Lee L.Y., Chen C.C., Teng C.C., Huang W.S., et al. Hericium erinaceusmycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade.  Transl. Med. 2016;14:78.

 

36. Yao W., Zhang J.-C., Dong C., Zhuang C., Hirota S., Inanaga K., Hashimoto K. Effects of amycenone on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration.  Biochem. Behav. 2015;136:7–12.

 

37. Nagano M., Shimizu K., Kondo R., Hayashi C., Sato D., Kitagawa K., Ohnuki K. Reduction of depression and anxiety by 4 weeks Hericium erinaceusBiomed. Res. 2010;31:231–237.

 

38. Inanaga K. Marked improvement of neurocognitive impairment after treatment with compounds from Hericium erinaceum: A case study of recurrent depressive disorder.  Med. Universe. 2014;3:46–48.

 

39. Okamura H., Anno N., Tsuda A., Inokuchi T., Uchimura N., Inanaga K. The effects of Hericium erinaceus(Amyloban^® 3399) on sleep quality and subjective well-being among female undergraduate students: A pilot study.  Med. Universe. 2015;4:76–78.

 

40. Vigna L., Morelli F., Agnelli G.M., Napolitano F., Ratto D., Occhinegro A., Di Iorio C., Savino E., Girometta C., Brandalise F., et al. Hericium erinaceusimproves mood and sleep disorders in patients affected by overweight or obesity: Could circulating pro-BDNF and BDNF be potential biomarkers?  Based Complement. Altern. Med. 2019;2019:7861297.